UnitedHealthcare - 2014 to Present
Aldara (imiquimod)
Drugs for the Skin : Drugs for the Skin
  • Acute Lymphoblastic Leukemia:
    Duration: 1 year(s)
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Reauthorization Required: No
    Duration of Reauthorization: N/A
    Drug Policy Based On: 1 of Clinical Pharmacology;NCCN Guidelines
    Diagnosis Types: Ph+ ALL
    ECOG Score Requirement Included in Policy: N/A
    Specialty Pharmacy is Required: Not Defined

    Aggressive Systemic Mastocytosis (ASM):
    Duration: 1 year(s)
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Reauthorization Required: No
    Duration of Reauthorization: N/A

    Chronic Myelogenous Leukemia, Gastrointestinal Stromal Tumor:
    Duration: 1 year(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A